Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-039810
Filing Date
2023-06-26
Accepted
2023-06-26 19:35:26
Documents
1
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4057
  Complete submission text file 0001209191-23-039810.txt   5583
Mailing Address C/O HYPERION THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 400 BRISBANE CA 94005
Business Address
Holles Natalie C. (Reporting) CIK: 0001580111 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 231043708

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations